Research Scientist - Inserm - Institute of Functional Genomics, Montpellier - France
Sylvie Claeysen is an INSERM Research Scientist working at the Institute of Functional Genomics, Montpellier, France. Sylvie is an expert in neuropharmacology, G protein-coupled receptors (GPCR), serotonin receptors and neurodegenerative disorders. In connection with a network of clinicians, chemists, and biotech companies she proposes innovative strategies to cure Alzheimer’s disease (α-secretase activation, Multi-Targeted drugs, biomarkers), based on a deep knowledge of molecular and cellular mechanisms induced by GPCRs in neuroprotection. Member of the Inserm cross-cutting Program Microbiota, she currently explores the potential of gut microbiota modulation as a new therapeutic avenue against Alzheimer’s disease. She has been awarded the Junior Faculty Award at the AD/PD™ 2013 (The Alzheimer’s & Parkinson’s Conference) and Chercheuse d’Avenir 2011 of the French Languedoc Roussillon Region. She was also a recipient of the Soroptimist International (French Union) medal (2011). She is a regular expert for national and international funding agencies and a member of the France Alzheimer’ Scientific Board.